The efficacy and safety of topical rapamycin/calcitriol for facial angiofibromas in patients with tuberous sclerosis complex: a prospective, double-blind randomized clinical trial.

CONCLUSIONS: This randomized clinical trial demonstrated that topical rapamycin-calcitriol combination therapy is an effective and safe regimen for TSC-related FAs. PMID: 32064596 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32064596?dopt=Abstract

Source: The British Journal of Dermatology - February 15, 2020 Category: Dermatology Authors: Chen PL, Hong JB, Shen LJ, Chen YT, Wang SJ, Liao YH Tags: Br J Dermatol Source Type: research